Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP690646.RAYE2gOT3H955HhLX0BblbK8wEA11LA7o9AYDV--jZYTU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP690646.RAYE2gOT3H955HhLX0BblbK8wEA11LA7o9AYDV--jZYTU130_assertion type Assertion NP690646.RAYE2gOT3H955HhLX0BblbK8wEA11LA7o9AYDV--jZYTU130_head.
- NP690646.RAYE2gOT3H955HhLX0BblbK8wEA11LA7o9AYDV--jZYTU130_assertion description "[With the addition of cardiac resynchronization therapy in these devices, new clinical trials that use cardiac resynchronization therapy as an early intervention in specific high risk heart failure populations and refinement of the CRT technique to improved optimal results are in progress.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690646.RAYE2gOT3H955HhLX0BblbK8wEA11LA7o9AYDV--jZYTU130_provenance.
- NP690646.RAYE2gOT3H955HhLX0BblbK8wEA11LA7o9AYDV--jZYTU130_assertion evidence source_evidence_literature NP690646.RAYE2gOT3H955HhLX0BblbK8wEA11LA7o9AYDV--jZYTU130_provenance.
- NP690646.RAYE2gOT3H955HhLX0BblbK8wEA11LA7o9AYDV--jZYTU130_assertion SIO_000772 18758929 NP690646.RAYE2gOT3H955HhLX0BblbK8wEA11LA7o9AYDV--jZYTU130_provenance.
- NP690646.RAYE2gOT3H955HhLX0BblbK8wEA11LA7o9AYDV--jZYTU130_assertion wasDerivedFrom befree-2016 NP690646.RAYE2gOT3H955HhLX0BblbK8wEA11LA7o9AYDV--jZYTU130_provenance.
- NP690646.RAYE2gOT3H955HhLX0BblbK8wEA11LA7o9AYDV--jZYTU130_assertion wasGeneratedBy ECO_0000203 NP690646.RAYE2gOT3H955HhLX0BblbK8wEA11LA7o9AYDV--jZYTU130_provenance.